Can You Induce Labor at 37 Weeks? The Science of Timing, Readiness, and Risk

You can medically induce labor at 37 weeks, and obstetricians do it routinely when continuing the pregnancy poses more risk to mother or baby than delivery does. But 37 weeks sits on the first day of the "early term" window, so an induction there is a deliberate trade-off rather than a neutral scheduling convenience. Whether it is advisable depends on why the induction is being considered, how the cervix is scoring, and what the fetus's lungs and brain are still finishing. This explainer walks through the physiology, the numbers, and the thresholds that separate a justified 37-week induction from an elective one.

What induction actually does to the uterus and cervix

Labor induction is not a single intervention. It is a set of mechanical and pharmacologic tools aimed at reproducing the sequence the body normally runs on its own: cervical ripening, then uterine contractions, then delivery. Each tool targets a different link in that chain.

The cervix is the gatekeeper. Before labor, it is a firm, closed, collagen-dense structure roughly 3 to 4 centimeters long. Ripening converts it into a soft, shortened, dilatable tissue through the breakdown of collagen cross-links and an influx of water and inflammatory cells. Prostaglandins drive this remodeling, which is why synthetic prostaglandin preparations can ripen a cervix that has not begun the process.

Contractions are a separate mechanism. Oxytocin receptors in the myometrium increase dramatically near term, and exogenous oxytocin exploits that receptor density to trigger coordinated contractions. Mechanical methods, such as a balloon catheter, work differently: they dilate the cervix and provoke local prostaglandin release by stretch. In plain terms, some methods soften the door, others push it open, and oxytocin tells the muscle to squeeze.

The reason 37 weeks matters here is that the uterus and cervix respond to these tools at any gestational age. Induction will usually work eventually. The question is not whether the uterus can be made to contract at 37 weeks, but whether the fetus is ready for the consequences.

Why 37 weeks is a threshold, not a plateau

Gestational age categories are not arbitrary. The American College of Obstetricians and Gynecologists defines early term as 37 weeks 0 days through 38 weeks 6 days, full term as 39 weeks 0 days through 40 weeks 6 days, and late term as 41 weeks 0 days through 41 weeks 6 days. That reclassification, adopted in 2013, was driven by outcome data showing that babies born at 37 weeks fare measurably differently from those born at 39 weeks.

The fetal brain and lungs are still maturing at 37 weeks. Lung surfactant, the substance that keeps air sacs from collapsing, is usually adequate by 37 weeks but not always fully optimized. Brain weight and white matter development continue through the final weeks. Babies born at early term have higher rates of transient breathing problems, feeding difficulty, and jaundice than those born at full term.

The counterintuitive detail is that the risk gradient is smooth, not a cliff. A 37-week baby is generally healthy and far safer than a 34-week baby. The elevated risk is small in absolute terms and concentrated in specific outcomes. That is why 37-week induction is reasonable for a medical indication but discouraged for convenience alone. A pregnancy induced at 37 weeks for a valid reason is a different clinical act than one induced because the family prefers a particular date.

Quantified context: what the evidence shows

The largest body of evidence on elective induction near term comes from the ARRIVE trial, published in 2018. It randomized more than 6,000 low-risk first-time mothers to elective induction at 39 weeks versus expectant management. Induction at 39 weeks reduced cesarean delivery and improved some perinatal outcomes without increasing serious neonatal complications. That trial studied 39 weeks, not 37, and that distinction is central.

For 37 weeks specifically, observational and trial data point in a more cautious direction. Early-term delivery, whether induced or spontaneous, is associated with higher rates of neonatal respiratory morbidity, NICU admission, and feeding challenges compared with full-term delivery. The absolute increases are modest, often in the range of a few additional cases per thousand births for serious respiratory outcomes, but they are consistent across studies.

Induction success rates also depend heavily on cervical readiness. A cervix that is unfavorable, meaning closed, firm, and long, predicts a longer induction and higher chance of cesarean. At 37 weeks, many first-time mothers have unfavorable cervices, which lengthens the process and raises the failure rate compared with induction at 39 or 40 weeks.

Timing of the decision matters as much as the number. An induction begun at 37 weeks 0 days and one begun at 37 weeks 6 days are a week apart in fetal maturity, and that week can shift lung readiness.

Reading the cervix: the Bishop score in practice

The Bishop score is the standard tool for judging whether a cervix is ready for induction. It assigns points across five features, and the total estimates the likelihood of a successful vaginal delivery after induction.

A total score of 8 or more is generally considered favorable, meaning the cervix is ripe and induction is likely to progress efficiently. A score of 6 or below is unfavorable, and a ripening agent is usually used before oxytocin. The exact cutoffs vary by protocol, which is one place where published thresholds diverge and clinicians reconcile them locally.

The professional caveat: the Bishop score was developed decades ago in an era of different obstetric practice, and its predictive accuracy is imperfect, especially in first-time mothers. Some units use it as a rough guide rather than a strict gate. Numbers inform the decision; they do not make it alone.

Edge cases where 37 weeks becomes the right call

Induction at 37 weeks is most defensible when the risks of continuing the pregnancy clearly outweigh the risks of early-term delivery. Several conditions fall into that category.

Preeclampsia with severe features, when it develops at or after 37 weeks, is typically managed by delivery rather than continued observation. The maternal risks of seizures, liver injury, and placental complications rise with time, and 37 weeks is the point at which delivery is generally favored.

Cholestasis of pregnancy, a liver condition causing intense itching and elevated bile acids, carries a risk of stillbirth that climbs with gestational age and with bile acid levels. Many protocols recommend delivery around 37 weeks when bile acids are high, with the specific threshold set by local guidance.

Diabetes, whether preexisting or gestational requiring medication, can increase the risk of stillbirth and macrosomia as pregnancy continues. Delivery timing is individualized, but 37 weeks is sometimes chosen when glucose control is poor or fetal growth is concerning.

Other edge cases include suspected fetal growth restriction with abnormal Doppler findings, placental abruption, and certain hypertensive disorders. In each, the calculation is the same: compare the hazard of staying pregnant against the hazard of being born a bit early. When the former is higher, 37 weeks wins.

Red flags that should prompt immediate contact with a clinician rather than a discussion about elective timing:

Severe headache, visual changes, or upper abdominal pain, which can signal preeclampsia Decreased fetal movement Vaginal bleeding or fluid leaking Regular painful contractions before 37 weeks, which may indicate preterm labor Fever or signs of infection Intense itching without a rash, particularly on the palms and soles

Misconceptions that distort the decision

The most common misconception is that 37 weeks is "full term." It is early term, and the distinction exists precisely because outcomes differ. Framing 37 weeks as full term leads families to underestimate the small but real neonatal risks.

Another misconception is that induction is simply a matter of scheduling. Induction is a medical procedure with a failure rate, a duration, and a set of complications, including uterine hyperstimulation, infection, and, in some cases, cesarean delivery. At 37 weeks with an unfavorable cervix, the failure rate is higher than at 39 weeks with a favorable one.

A third misconception is that "natural" methods can reliably induce labor. Castor oil, herbal preparations, nipple stimulation, and sexual intercourse have weak or inconsistent evidence. Some carry real risks, such as the dehydration and cramping associated with castor oil. These are not substitutes for medical induction and should not be presented as equivalent.

The plain-language version: induction is a tool with a purpose, not a dial you turn for convenience, and at 37 weeks the tool is sharper on risk than many people assume.

Practical actions and thresholds

If you are considering or facing induction at 37 weeks, the useful steps are concrete rather than abstract.

Confirm the gestational age. Dating ultrasound in early pregnancy is the most reliable anchor, and it determines whether "37 weeks" is truly 37 weeks. An off-by-one-week error changes the risk calculation.

Establish the indication. Ask explicitly why induction is being recommended now rather than at 39 weeks. A clear medical reason, such as severe preeclampsia or cholestasis with elevated bile acids, is different from a soft preference.

Request a cervical assessment. The Bishop score informs how the induction will be done and how long it may take. A low score usually means ripening first.

Discuss the method. Ripening agents, mechanical balloons, and oxytocin have different profiles, and the choice depends on the cervix, the fetus, and local protocol.

Plan for monitoring. Early-term induction typically involves continuous fetal monitoring and a longer anticipated hospital stay. Ask what happens if the first method does not work.

Reconcile the thresholds you are given. Published guidance sets delivery timing for preeclampsia, cholestasis, and diabetes at slightly different points, and clinicians tailor these to the individual. If two sources disagree, ask which one applies to your situation and why.

Avoid self-induction methods. None are reliably effective, and some are unsafe.

Limitations and the honest bottom line

The evidence base for 37-week induction is strongest for specific medical conditions and weaker for elective timing. Much of the data is observational, which means it cannot fully separate the effect of gestational age from the reasons behind the induction. The ARRIVE trial supports elective induction at 39 weeks, not 37, and extrapolating it downward is not justified.

Outcome statistics are population-level. They describe averages across thousands of births and cannot predict what will happen in a single pregnancy. A family weighing a 37-week induction is making a decision under uncertainty, guided by the indication, the cervical score, and the fetal assessment.

The honest summary is that induction at 37 weeks is medically possible, frequently appropriate for a real indication, and not a neutral scheduling choice. The physiology of cervical ripening and uterine contraction will cooperate at 37 weeks. The question is whether the fetus's remaining maturation is worth the wait. When the answer is yes and the pregnancy is healthy, 39 weeks remains the better target. When the answer is no because of maternal or fetal risk, 37 weeks is a defensible and often necessary decision made with a clinician who can weigh the specific circumstances.